ORIGINAL ARTICLE
Definitive radiotherapy for cervical esophageal cancer Caineng Cao, MD, Jingwei Luo, MD,* Li Gao, MD, Guozhen Xu, MD, Junlin Yi, MD, Xiaodong Huang, MD, Kai Wang, MD, Shiping Zhang, MD, Yuan Qu, MD, Suyan Li, MD, Jianping Xiao, MD, Zhong Zhang, MD Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, People’s Republic of China.
Accepted 10 December 2013 Published online 3 April 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/hed.23572
ABSTRACT: Background. The role of contemporary radiotherapy (RT)
Results. The median follow-up time was 17.1 months. For all patients, the overall 2-year local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), and overall survival (OS) rate was 68.3%, 83.3%, 75.7%, and 47.6%, respectively. Conclusion. Definitive RT accomplished a satisfactory local control rate and contributed to organ preservation for patients with cervical esophageal C 2014 Wiley Periodicals, Inc. Head Neck 37: 151–155, 2015 cancer. V
has not yet been elucidated, mainly because of the low incidence of cervical esophageal cancer. The purpose of this study was to analyze the outcome in patients with cervical esophageal cancer treated with definitive RT. Methods. A total of 115 patients with cervical esophageal cancer treated with definitive RT during January 2001 through April 2012 in our center were analyzed. Eighty patients received RT alone and 35 patients received concurrent chemoradiotherapy with cisplatin administered either weekly (30 mg/m2) or every 3 weeks (80 mg/m2).
KEY WORDS: cervical esophageal cancer, treatment, radiotherapy, survival, organ preservation
INTRODUCTION
PATIENTS AND METHODS
Cervical esophageal cancer is relatively uncommon, representing
Definitive radiotherapy for cervical esophageal cancer Caineng Cao, MD, Jingwei Luo, MD,* Li Gao, MD, Guozhen Xu, MD, Junlin Yi, MD, Xiaodong Huang, MD, Kai Wang, MD, Shiping Zhang, MD, Yuan Qu, MD, Suyan Li, MD, Jianping Xiao, MD, Zhong Zhang, MD Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, People’s Republic of China.
Accepted 10 December 2013 Published online 3 April 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/hed.23572
ABSTRACT: Background. The role of contemporary radiotherapy (RT)
Results. The median follow-up time was 17.1 months. For all patients, the overall 2-year local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), and overall survival (OS) rate was 68.3%, 83.3%, 75.7%, and 47.6%, respectively. Conclusion. Definitive RT accomplished a satisfactory local control rate and contributed to organ preservation for patients with cervical esophageal C 2014 Wiley Periodicals, Inc. Head Neck 37: 151–155, 2015 cancer. V
has not yet been elucidated, mainly because of the low incidence of cervical esophageal cancer. The purpose of this study was to analyze the outcome in patients with cervical esophageal cancer treated with definitive RT. Methods. A total of 115 patients with cervical esophageal cancer treated with definitive RT during January 2001 through April 2012 in our center were analyzed. Eighty patients received RT alone and 35 patients received concurrent chemoradiotherapy with cisplatin administered either weekly (30 mg/m2) or every 3 weeks (80 mg/m2).
KEY WORDS: cervical esophageal cancer, treatment, radiotherapy, survival, organ preservation
INTRODUCTION
PATIENTS AND METHODS
Cervical esophageal cancer is relatively uncommon, representing
